Efficacy of Minimally Invasive Surgery on Giant Cell Tumour of the Bone: A Systematic Review

Maria Florencia Deslivia; Sherly Desnita Savio; Made Wahyu Dharmapradita; I Gede Eka Wiratnaya

doi:10.3889/oamjms.2019.731

Authors

Maria Florencia Deslivia Orthopaedics and Traumatology Department, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Indonesia
Sherly Desnita Savio Orthopaedics and Traumatology Department, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Indonesia
Made Wahyu Dharmapradita Orthopaedics and Traumatology Department, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Indonesia
I Gede Eka Wiratnaya Orthopaedics and Traumatology Department, Faculty of Medicine Udayana University, Sanglah General Hospital, Denpasar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2019.731

Keywords:

Endoscopy, Osteoscopy, Giant cell tumour, benign tumour, Minimally invasive surgery

Abstract

BACKGROUND: Although major reconstructive surgeries in the form of excision and reconstruction have been the mainstay treatment for Giant Cell Tumour (GCT) of the bone, its recurrence rate remains high and poses various morbidities such as implant failure or skin breakdown. Minimal invasive surgery (MIS) techniques, which has gained popularity mostly in other fields in orthopaedic surgery, are being introduced as an alternative to limit the surgical complications while achieving the best possible outcome. Until now, there has been no literature summarising the evidence of MIS outcome in treating GCT of the bone.

AIM: The purpose of this systematic review was to investigate the efficacy of this relatively new treatment.

METHODS: We comprehensively searched PubMed, EMBASE, and Cochrane Library to search for studies about MIS for GCT of the bone treatment up to March 1, 2019. The selection of appropriate studies was performed by two independent investigators based on PRISMA guideline. Given the limited number of studies, there was no restriction in terms of patientâ€™s demographics, the specific minimally invasive surgical method, and publication status.

RESULTS: We found 120 articles from the database. After evaluating full text, 5 articles (16 patients) were found to be eligible. The minimally invasive methods were curettage, cryosurgery, and argon beam coagulator. The visualisation methods include a computer-assisted navigation system, endoscope, otoscope, CT, and MRI. Location of tumours includes axial and long bones. The follow-up period ranges from 7 to 126 months. The functional and oncological outcome was found to be satisfying with no recurrence or complications.

CONCLUSION: In conclusion, MIS is a familiar method in orthopaedic surgery with potential expansion in tumour field. The current evidence shows that this approach for GCT results in good functional outcome, with low risk of recurrence.